Showing 1 - 10 of 50
In this paper, we develop a simple model of the benefits and costs of being on a waiting list. The model shows that complex factors are in operation, implying that a shorter waiting time need not necessarily be preferred to a longer waiting time. We also present an empirical study, where a...
Persistent link: https://www.econbiz.de/10005649180
This paper reconsiders the equity issue in Swedish health care utilisation previously analyzed by Gerdtham (Health Economics 6, 303-319, 1997) within the framework of the standard two-part model. Departing from the user/nonuser distinction, we use the more flexible framework of the finite...
Persistent link: https://www.econbiz.de/10005649172
Intresse och användning av hälsoekonomiska utvärderingar som underlag vid beslut om pris och subentionering av läkemedel ökar i de flesta länder. Många länder har infört mer eller mindre formella krav på hälsoekonomisk dokumentation inför sådana beslut och ett flertal länder och...
Persistent link: https://www.econbiz.de/10005207198
In this paper we test for existence of cointegration between health expenditure and GDP using data from 19 OECD countries for the period 1960-1995. Country-by-country and panel results based on the Johansen multivariate likelihood-based inference and a new panel test for cointegration rank are...
Persistent link: https://www.econbiz.de/10005771158
There are few studies investigating the consequences of osteoporotic (low bone density) fractures in terms of costs and health outcomes. The purpose of this Swedish pilot study is to assess the costs and quality of life related to fractures of the hip, spine, wrist and shoulder and further to...
Persistent link: https://www.econbiz.de/10005771160
Background: The Fracture Intervention Trial (FIT) showed that the bisphosphonate alendronate reduces the risk of fractures in women with low bone mass in the United States. <p> Objective: To estimate the cost-effectiveness (cost per life-year gained and cost per quality-adjusted life-year, QALY,...</p>
Persistent link: https://www.econbiz.de/10005771182
Background <p> Economic evaluation of treatments in multiple sclerosis (MS) presents a challenge. The disease affects a number of different body functions and leads to severe disability over time, without however a strong effect on mortality. At onset, the majority of patients will have...</p>
Persistent link: https://www.econbiz.de/10005771183
This paper investigates the effects of different health systems on cost efficiency in inpatient health care among the OECD countries. The results indicate that public contract systems are less efficient and that public integrated health systems are more efficient than public reimbursement systems.
Persistent link: https://www.econbiz.de/10005771184
In this study we report an attempt to measure the value adult Swedes impute to an increased survival probability at high ages. A rating scale between the worst possible quality of life (=1) and the best possible quality of life (=10) is used to indicate the quality of life a person expects to...
Persistent link: https://www.econbiz.de/10005190820
The average cesarean section rate in Sweden more than doubled during the 1970s, and amounted to 12-3 percent in 1983. After that, there was a steady-state for a couple of years and towards the end of the 80s even a small decrease, to 10.9 percent in 1990. In the early 90s, there was a slight...
Persistent link: https://www.econbiz.de/10005190830